ABSTRACT Background: Obesity is associated with multiple diseases. Bariatric surgery is the most effective therapy for severe obesity that can reduce body weight and obesity-associated morbidity. The metabolic alterations associated with obesity and respective changes after bariatric surgery are incompletely understood. Objective: We comprehensively assessed metabolic alterations associated with severe obesity and distinct bariatric procedures. Design: In our longitudinal observational study, we applied a 1 Hnuclear magnetic resonance-based global, untargeted metabolomics strategy on human serum samples that were collected before and repeatedly #1 y after distinct bariatric procedures [i.e., a sleeve gastrectomy, proximal Roux-en Y gastric bypass (RYGB), and distal RYGB]. For comparison, we also analyzed serum samples from normal-weight and less-obese subjects who were matched for 1-y postoperative body mass index (BMI) values of the surgical groups. Results: We identified a metabolomic fingerprint in obese subjects that was clearly discriminated from that of normal-weight subjects. Furthermore, we showed that bariatric surgery (sleeve gastrectomy and proximal and distal RYGB) dynamically affected this fingerprint in a procedure-dependent manner, thereby establishing new fingerprints that could be discriminated from those of BMI-matched and normal-weight control subjects. Metabolites that largely contributed to the metabolomic fingerprints of severe obesity were aromatic and branched-chain amino acids (elevated), metabolites related to energy metabolism (pyruvate and citrate; elevated), and metabolites suggested to be derived from gut microbiota (formate, methanol, and isopropanol; all elevated). Conclusion: Our data indicate that bariatric surgery, irrespective of the specific kind of procedure used, reverses most of the metabolic alterations associated with obesity and suggest profound changes in gut microbiome-host interactions after the surgery. This trial was registered at clinicaltrials.gov as NCT02480322.
INTRODUCTION
Obesity is associated with numerous diseases (1) , but the underlying pathophysiologic processes and metabolic pathways are incompletely understood. Bariatric surgery represents the most-effective therapy for weight loss and obesity-related diseases (2-4) and comprises different operative procedures that aim at reducing food intake or the digestion and absorption of ingested macronutrients by manipulating the gastrointestinal tract. Several procedures further alter gastrointestinal hormone secretion (5, 6) , biliary acid handling, and the gut microbiome (5) .
A global metabolomic analysis (7-9) represents a mostpromising approach to comprehensively characterize metabolic changes associated with obesity and after bariatric surgery because it can capture a wide range of metabolic processes at the same time. The metabolome can be considered an integrative downstream product of the genome, transcriptome, proteome, and gut microbiome-host interaction and also behavioral aspects such as dietary habits. A clear advantage of a nuclear magnetic resonance (NMR) 7 metabolomic analysis is that it does not rely on the measurement of a single metabolite-associated peak, but it considers the spectrum as a whole (10) . The NMR profile contains qualitative and quantitative information on the hundreds of different small molecules present in the sample (11) (12) (13) that constitute a metabolic fingerprint. The metabolome is affected by perturbations that are due to physiologic, pathologic, and iatrogenous factors (14) (15) (16) . A statistical analysis of NMR profiles provides information on the metabolite-pattern alterations and their associations with pathologic conditions as have been shown in a series of previous studies (17) (18) (19) (20) .
Only a limited number of studies in humans have been carried out to explore the metabolomic profile of obesity and respective changes after bariatric surgery (21) (22) (23) (24) (25) (26) . Also, previous work has focused mostly on a single kind of bariatric surgery [i.e., Roux-en Y gastric bypass (RYGB)], which has left the question open of 1 Supported by the Italian Farmacogenomic Foundation Fiorgen (EG). 2 Supplemental Figure 1 and Supplemental Tables 1 and 2 are available from the "Online Supporting Material" link in the online posting of the article and from the same link in the online table of contents at http://ajcn. nutrition.org.
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whether different bariatric procedures produce distinct inherent metabolic signatures.
The objective of the current study was to comprehensively assess metabolic alterations associated with severe obesity and distinct bariatric procedures. Therefore, we implemented an 1 H-NMR-based metabolomic analysis to 1) compare the NMR metabolic fingerprint as assessed in serum samples of severely obese patients with that of normal-weight control subjects, 2) follow up changes in the metabolic fingerprint over 1 y after 3 distinct bariatric procedures, and 3) compare the metabolic fingerprints established 1 y after the different surgeries with those of BMI-matched and normal-weight control subjects.
METHODS

Patients
Serum samples from 106 severely obese patients of the Interdisciplinary Obesity Center, St. Gallen, were collected before and 3, 6, 9, and 12 mo after bariatric surgery between May 2010 and May 2012. In addition, serum samples from 19 normalweight volunteers and from 30 subjects with BMI that was matched to those achieved by the severely obese subjects 12 mo after the bariatric surgery were also collected. Each sample (total n = 465) was stored in the Da Vinci European Biobank (www. davincieuropeanbiobank.org) repository.
Surgical procedures
Severely obese patients qualified for bariatric surgery according to international guidelines (27) . A total of 19 patients underwent a sleeve gastrectomy, 27 patients underwent a proximal RYGB procedure, and 60 patients underwent a distal RYGB procedure (Supplemental Figure 1) (28) . The allocation of patients to the distinct bariatric procedures was based on clinical characteristics such as the degree of obesity, comorbidities, eating behaviors, and the patient preferences.
Clinical evaluation
Body weight and height were measured, and the body composition was assessed with the use of a multifrequency bioelectrical impedance analysis (Nutriguard M; Data Input).
NMR sample preparation
Serum samples, which were collected according to standardized clinical procedures (i.e., drawn in the morning after an overnight fast), were frozen at 2808C and shipped in dry ice to the metabolomic laboratory. Samples received from St. Gallen were stored at 2808C until the NMR analysis. Frozen serum samples were thawed at room temperature and shaken before use. According to standard procedures for a metabolomics analysis (29) , a total of 300 mL sodium phosphate buffer [70 mmol Na 2 HPO 4 /L; 20% (volume:volume) 2 H 2 O; 0.025% (volume:volume) NaN 3 ; and 0.8% (weight:volume) sodium trimethylsilyl (2,2,3,3-2 H 4 )propionate; pH 7.4] was added to 300 mL of each plasma sample, and the mixture was homogenized on a vortex for 30 s. A total of 450 mL of this mixture was transferred into a 4.25-mm NMR tube (Bruker BioSpin srl) for analysis.
NMR-spectra acquisition and processing
NMR spectra for all samples were acquired with the use of a Bruker spectrometer (Bruker Biospin srl) operating at 14.1 T (600.13-MHz proton Larmor frequency) equipped with a triple resonance inverse cryo probe cryoprobe, an automatic tuningmatching unit, and an automatic sample changer. Car-PurcellMeiboom-Gill pulse sequence (30) spectra (that contained signals arising mostly from low-molecular mass metabolites), diffusion-edited spectra (31) (that contain signals arising mostly from macromolecules), and one-dimensional-nuclear Overhauser effect spectroscopy (32) spectra (that contain both kinds of signals) were measured. For each spectrum, the region between 6.0 and 4.5 ppm, which contained the residual water signal, was removed from the subsequent analysis. Each onedimensional spectrum in the range between 0.2 and 10.0 ppm was segmented into 0.02-ppm chemical shift buckets, and the corresponding spectral areas were integrated with the use of AMIX software (version 3.8.4; Bruker BioSpin), which gave a total of 466 variables. Bucketing is a means to reduce the number of total variables and to compensate for small shifts in the signals. Spectra were used without normalization (33) . A total of 30 metabolites were identified as follows-amino acids: alanine, arginine, glutamine, glycine, histidine, leucine, isoleucine, valine, tyrosine, and phenylalanine; carboxylic acid anions: acetate, acetoacetate, citrate, formate, 3-hydroxybutyrate, lactate, and pyruvate; other metabolites: creatine, creatinine, dimethyl sulfone, glucose, hypoxanthine, isopropanol, methanol, propanol, lipoproteins, LDL1, VLDL1, trimethylamine-N oxide (TMAO), and urea. Of these, 24 metabolites showed variations in the patients over the postsurgical course.
All resonances of interest were manually checked, and signals were assigned on template one-dimensional NMR profiles with the use of matching routines of AMIX 7.3.2 software (Bruker BioSpin) in combination with the BBIOREFCODE version 2-0-0 reference database (12) and published literature when available. For the identification of new signals belonging to DMSO 2 , 2-dimensional NMR experiments and the spiking of reference compounds were done. All calculations were made with the use of scripts written in our laboratory with the use of the R language version: 3.0.2 (34) .
Ethics
Written informed consent was obtained from all patients, and the study was approved by the local ethical committee in St. Gallen.
Statistics
Data were analyzed with the use of ANOVA, mixed linear models, and post hoc Tukey's, Student's t, Mann-Whitney U, and chi-square tests as appropriate. According to Cohen's formulation of power calculation and with the use of a t test as model, 106 samples in the severely obese group and 16 samples in the normal-weight group were sufficient to detect medium effects (d = 0.7) at a significance level of 0.05 with a statistical power of 80%. In the case of the pairwise analysis of the samples collected at different time points, 106 samples in each group could detect even small effects (d = 0.2) at a significance level of 0.05 with a statistical power of 80%.
Unsupervised and supervised statistical analysis tools were applied to study the metabolomics profile. The statistical procedure used for the classification was a combination of a partial least-squares and canonical analysis (PLS-CA),that was used as the method for discrimination (e.g., before compared with after surgery). The accuracy of the classification was assessed by means of a double cross-validation scheme (35, 36) . The original data set was split into a training set (80% of the samples) and a test set (20% of the samples) before any step of statistical analysis. The number of PLS components was chosen on the basis of a 5-fold cross-validation that was performed on the training set only, and the best model was used to predict the samples in the test set. The whole procedure was repeated 200 times with a Monte Carlo crossvalidation scheme, and the results were averaged.
To be able to follow the changes of the same subject over time, instead of extrapolating the distinctive differences between the sets taken as a whole, a supervised pairwise multilevel partial least-squares (37) analysis was applied.
To assess which metabolites (i.e., NMR peaks) were significantly different between different subject groups, Mann-Whitney U tests were used. The course of single metabolites after the surgeries was analyzed by calculations of mixed linear models including the factors "time" for different time points in relation to the surgery and "procedure" for comparison between the 3 different surgical procedures. Thereafter, a pairwise comparison of different time points and different procedures was performed only when the main factor (i.e., time or procedure) or the interaction term of both factors reached significance. P # 0.05 was considered statistically significant.
RESULTS
Metabolomic fingerprint of severe obesity
Clinical data of the severely obese and normal-weight groups are provided in Table 1 . The first analysis of the metabolomic data set of the 2 groups focused on the identification of a clear metabolomic fingerprint of obesity. With a discriminant analysis, it was possible to obtain a cross-validated accuracy of 94.0% with a sensitivity of 92.2% and specificity of 94.2%.
In Table 2 , the metabolites that significantly differed between the 2 groups are reported. The amino acid profile showed a markedly differential pattern in the 2 groups. Although serum glutamine and histidine concentrations were lower in severely obese subjects than in normal-weight subjects (both P , 0.005), concentrations of alanine, the aromatic amino acids phenylalanine and tyrosine, and the branched-chain amino acids (BCAAs) leucine, isoleucine, and valine were significantly higher in the severely obese subjects (all P , 0.05). Another group of metabolites that showed significant differences between the severely obese and normal-weight subjects consisted of several organic acids. Specifically, the severely obese patients showed significantly higher citrate, formate, and pyruvate concentrations (all P , 0.03), and acetoacetate showed a trend in this direction (P = 0.076). Finally, the metabolites glucose, isopropanol, methanol, and VLDL1 were significantly higher in the severely obese subjects than in normal-weight subjects (all P , 0.005).
Changes in metabolomic fingerprints after distinct bariatric procedures
Body weight and BMI were markedly decreased after all of the 3 bariatric procedures with the amount of lost weight being greatest during the first postoperative 3-mo interval and lowest during the last postoperative 3-mo interval. Irrespectively of the kind of surgery, patients lost a substantial amount of fat mass and lean body mass ( Table 3) .
A classification analysis by the PLS-CA was performed on all samples together and separately for each bariatric procedure. Significant differences were observed between pre-operative and postoperative serum samples with discrimination accuracies . 90% as calculated by a cross-validation analysis. The results of respective analyses are shown in Table 4 for Carr-PurcellMeiboom-Gill spectra. Similar results were obtained when nuclear Overhauser effect spectroscopy and diffusion-edited spectra were analyzed (data not shown). Separate analyses of the distinct bariatric procedures revealed that the accuracies of discrimination were very high for the distal RYGB, lower for the proximal RYGB, and the lowest for the sleeve gastrectomy.
Subsequently, a multilevel partial least-squares analysis was used to analyze the time-dependent changes within each patient and exploiting the fact that, for a subgroup of 59 individuals (35 subjects in the distal RYGB group, 22 subjects in the proximal RYGB group, and 2 subjects in the sleeve gastrectomy group), all 5 time-dependent samples were available (Table 4) . Results revealed that the accuracies for the comparisons between the different collection periods were even higher than the PLS-CA classification analysis. The multilevel comparison between pre-operative and postoperative metabolomics profiles revealed a good discrimination, as did comparisons between different times after surgery.
To search for specific inherent effects of the different bariatric procedures on the metabolomic fingerprint, a discrimination analysis between the 3 different procedures was performed with postsurgery samples (i.e., at 3, 6, 9, and 12 mo). The accuracies obtained suggest that significant differences in metabolic profiles between the 3 procedures existed but tended to be less pronounced 12 mo after surgery. Overall, distal RYGB patients were discriminated from the other 2 procedures with a much-higher accuracy than for the discrimination between the proximal RYGB and sleeve gastrectomy patients ( Table 5) .
Results on mixed linear models on the course of single metabolites after the surgeries are summarized in Supplemental Table 1 . Irrespective of the specific bariatric procedure, the concentrations of the amino acids (Figure 1) arginine, glutamine, glycine, and histidine increased (all P # 0.001) without any significant differences in these increases between the 3 procedures (all P . 0.110 for the time 3 procedure interaction term). In contrast, concentrations of the BACCs isoleucine, leucine, and valine as well as of the aromatic amino acids phenylalanine and tyrosine decreased after the surgery (all P , 0.001), again without any significant differences between the 3 procedures except for valine, which showed a somewhat weaker reduction after gastric sleeve resection [all P . 0.109 (except for valine; P = 0.006) for the time 3 procedure interaction term].
As regards carboxylic acid anions (Figure 2 ), pyruvate concentrations progressively decreased after the surgery (P , 0.001) without any differences between the 3 different procedures (P = 0.155 for the interaction term). Concentrations of acetoacetate, citrate, and 3-hydroxybutyrate showed temporary increases, which were most pronounced during the first months after the surgery (all P , 0.001) with only citrate showing a significant time 3 procedure interaction (P = 0.003). Formate showed an increase after the surgeries (P , 0.001) without any differences between the 3 procedures (P = 0.849 for the interaction term).
With regard to the remaining identified metabolites (Figure 3) , isopropanol, methanol, and propanol concentrations showed a rapid reduction that persisted until 1 y after all surgical procedures (all P , 0.001, P . 0.129 for interaction terms). Total lipoprotein concentration as well as the VLDL1 fraction decreased after all surgeries (both P , 0.001, P . 0.082 for interaction terms), whereas the LDL1 fraction increased (P , 0.001, P = 0.965 for interaction term). We showed a marked increase in DMSO 2 and TMAO concentrations after the surgery (both P , 0.001) with the increases differing between the 3 procedures (P , 0.001 for both interaction terms). Although the increase in DMSO 2 was most prominent after the distal RYGB procedure, there appeared to be no increase of TMAO after the gastric sleeve resection.
Comparison of 12-mo postoperative metabolomic fingerprints with BMI-matched and normal-weight controls Table 6 shows the comparisons of the 12-mo postoperative anthropometric and body-composition data of the 3 bariatric groups with those of the BMI-matched and normal-weight controls. The 3 bariatric groups showed a markedly lower fat percentage than that of BMI-matched controls (overall P , 0.001).
Discrimination analyses revealed that, 12 mo after surgery, the severely obese patients who had undergone different bariatric procedures could, on the basis of their metabolomic fingerprints, still be discriminated from the BMI-matched and normal-weight controls with an overall accuracy of 83.3% and 87.9%, respectively. When the distinct bariatric procedures were analyzed separately, the metabolomic fingerprints of the distal RYGB group could be discriminated most accurately from those of the 2 control groups (88.3% compared with BMI-matched controls; 90.0% compared with normal-weight controls), whereas the discrimination accuracies 12-mo after the proximal RYGB (74.0% and 76.4%, respectively) and the sleeve gastrectomy (74.3% and 76%, respectively) were somewhat lower.
Analyses of single metabolites pointed to a number of specific metabolic alterations in the 3 bariatric groups 12-mo after the surgery compared with the BMI-matched and normal-weight control groups (Supplemental Table 2 ).
DISCUSSION
Our results indicate that a severely obese individual can be discriminated from normal-weight subjects in an NMR metabolomic Data are accuracies of discrimination. Distal denotes a distal RYGB, proximal denotes a proximal RYGB, and sleeve denotes a sleeve gastrectomy. 0 denotes the serum sampling before surgery, and 3, 6, 9, and 12 mo denote the respective months after surgery. For the sleeve surgery, the paired samples were too few to perform an MPLS analysis. Numbers of serum samples before surgery and 3, 6, 9, and 12 mo after surgery were as follows-distal: 60, 58, 58, 57, and 39, respectively; proximal: 27, 26, 27, 25, and 24, respectively; and sleeve: 19, 14, 13, 10, and 8, respectively. MPLS, multilevel partial least squares; PLS-CA, partial least squares and canonical analysis. analysis of a single fasting morning serum sample with an accuracy of 94%. This finding confirms the existence of a specific metabolomic fingerprint of severe obesity. Furthermore, our results show that bariatric surgery markedly affected this metabolomic fingerprint in a procedure-dependent manner, and subjects who had undergone bariatric surgery could be discriminated from BMI-matched and normal-weight controls with an accuracy .83%. These results speak for the existence of a metabolomic fingerprint of bariatric surgery that can even be subdivided, albeit with a lower accuracy, into distinct procedure-specific fingerprints.
A global metabolomic analysis, as we performed in our study, captures a wide range of metabolic processes that integrate behavioral factors such as dietary habits and gut microbiome-host interactions. Identified metabolites that strongly contribute to the fingerprint of severe obesity and bariatric surgery can, in principle, be derived from many different sources such as the human or gut-microbiota metabolism or the intake of specific food components. In this context, note that we previously documented distinct dietary habits in our severely obese patients compared with normal-weight controls (38) and showed that dietary habits markedly changed after RYGB surgery (39) . As regards the metabolomic fingerprint of severe obesity, several characteristics need to be pointed out. The first prominent alteration was a distinct amino acid profile that was characterized by elevated concentrations of alanine, the aromatic amino acids phenylalanine and tyrosine, and the BCAAs leucine, isoleucine, and valine as well as reduced concentrations of glutamine and histidine. Although our findings on alanine, the aromatic amino acids, and the BCAAs are well in line with previous studies (40) (41) (42) , findings on lower glutamine and histidine concentrations are at variance with those of a recent study (40) , which applied targeted tandem mass spectrometry and showed glutamine concentrations were increased and histidine concentrations were unaltered in obese subjects. After bariatric surgery, -independent of the type of procedure, we observed an increase in arginine and glutamine and a reduction of aromatic amino acids as well as of BCAA concentrations, which indicated that surgically induced weight loss can, at least in part, normalize the alterations in amino acid metabolism associated with obesity. Of note, a study (43) has also documented a reduction in aromatic amino acids and BCAA concentrations 1 and 6 mo after RYGB surgery, which was not entirely explained by the weight loss or negative energy balance per se. This finding suggests that the respective changes in the amino acid metabolism represent an inherent effect of the RYGB procedure. However, to our knowledge, our current results shed new light on and extend these previous findings by showing that 1) similar changes can also be shown after other bariatric procedures (i.e., sleeve gastrectomy) and 2) respective changes persist over a postoperative period $12 mo (i.e., a time when the degree of negative energy balance is diminished).
The clinical relevance of disturbed amino acid metabolism in obesity is increasingly recognized. Although elevated aromatic amino acids concentrations have been associated with depression (40) (i.e., a prevalent condition in severely obese subjects), elevated BCAAs have been linked to an impairment of glucose metabolism and insulin action (40, 42, 44) . Furthermore, a study indicated that elevated aromatic amino acids and BCAA concentrations strongly predicted the prospective development of diabetes (45) . With this background, it might be speculated that the observed reduction in respective amino acid concentrations after bariatric surgery contributes to the well-documented preventive (4, 46) and therapeutic (46) effects of the surgical intervention on type 2 diabetes.
The second prominent alteration in the metabolomics fingerprint of severe obesity was the elevation of a number of carboxylic acid anions, some of which, such as citrate and pyruvate, represent key metabolites in energy metabolism. These findings, in conjunction with previous findings in rats (47) , may provide a hint of an altered tricarboxylic acid cycle activity or mitochondrial function associated with obesity, which again could be directly linked to amino acid-profile alterations (45, 48) . After bariatric surgery, pyruvate concentrations showed a gradual normalization, whereas citrate concentrations showed a temporary increase. The latter finding likely represents a consequence of the profound catabolic state during the first months after surgery. In line with this notion is the observation that the ketone bodies acetoacetate and 3-hydroxybutyrate, which are well-known markers of catabolism, likewise showed a strong increase early after the surgery while normalizing later on. This temporary increase in ketone bodies likely reflects an increased lipolytic activity, but the ketogenesis may also be fueled by an enhanced breakdown of isoleucine, leucine, phenylalanine, and tyrosine as suggested by the observed rapid postoperative drop in the serum concentrations of these ketogenic amino acids.
Another observation in our study was the markedly enhanced concentrations of isopropanol and methanol in severely obese subjects. Because both of these alcohols are not metabolites of regular human metabolism but, rather, of bacterial metabolism (49) , it can be speculated that elevated serum concentrations of methanol and isopropanol in obese subjects are derived from an altered gut microbiota composition. The concurrent finding of higher formate concentrations in obese subjects compared with normal-weight subjects also pointed in this direction because formate is closely linked to enterobacteria's anaerobic methanol metabolism (50) . Obese subjects have been shown to display a distinct gut microbiota composition (51, 52) and probably also a reduced bacterial diversity (53) . Thus, we hypothesize that the altered gut microbiome in obese subjects leads the production of distinct bacterial metabolites that are taken up into the human bloodstream. Such a scenario may have important clinical consequences. For instance, considering that obesity is associated with an increased risk of a premature cognitive decline (54) it is tempting to speculate that the enhanced serum concentration of neurotoxic metabolites formate, isopropanol, and methanol play an important role in this context.
After bariatric surgery, the increased concentrations of methanol and isopropanol rapidly normalized irrespectively of the specific kind of procedure performed, whereas formate concentrations remained higher than those in BMI-matched and normal-weight control subjects. These findings might point to postoperative changes in the gut microbiota composition as has previous been documented in humans (22, 55) , rats (56) , and mice (57) after RYGB surgery. Fittingly, previous studies have also documented changes in bacterial metabolites in human (26) and rat (58) urine samples after RYGB. The recent transplantation experiments of gut microbiota samples collected from mice after RYGB surgery to mice raised in a germ-free environment provided strong evidence of a major contribution of microbiome alterations to the weight-loss effects of RYGB surgery (57) . The altered intraluminal milieu that results from the rapid passage of undigested food into the distal part of the gut as well as from the altered biliopancreatic juice flow may be contribute to the microbiotic changes associated with RYGB surgery. However, the putative gut microbiome markers isopropanol and methanol also decreased to a similar extent after the sleeve gastrectomy (i.e., a procedure that leaves the flow of nutrients and the biliopancreatic juice unaltered). Thus, it may be speculated that postoperative changes in dietary habits or other mechanisms also play a role in shaping the gut microbiome (59, 60) .
A very impressive finding in our study was the marked increase in dimethyl sulfone concentrations after all bariatric procedures, which was most pronounced after the distal RYGB. Of note, the metabolite dimethyl sulfone was barely present in the preoperative serum samples as well as in those of normal-weight and BMI-matched controls. In humans, dimethyl sulfone can be produced in small amounts as an intermediate metabolite of methionine metabolism (61) . Previous studies have also detected dimethyl sulfone in urine samples after the ingestion of asparaguses (62) and onions (63) . The consumption of cooked vegetables, beer, rice, and port wine could likewise raise the concentrations of dimethyl sulfone in human biofluids because they contain dimethyl sulfide, which can be metabolized to dimethyl sulfone (61) . However, it appears unlikely that the low concentrations of dimethyl sulfone generated via methionine metabolism and food dimethyl sulfide metabolism can explain the robust and consistent rise in serum dimethyl sulfone concentrations in our patients after bariatric surgery. Alternatively, the high concentrations of dimethyl sulfone may derive from gut microbiota metabolism (61), again reflecting a postoperative change in the gut microbiome. The postoperative increase in dimethyl sulfone concentrations was most pronounced in patients who had undergone a distal RYGB surgery. Accordingly, this bariatric procedure also produced a metabolomic fingerprint that could be discriminated with the highest accuracy from that of all other groups (i.e., proximal RYGB, sleeve gastrectomy, BMI-matched controls, normalweight controls, pre-operative state). The distal RYGB, in contrast with other investigated bariatric procedures, establishes a state of strong malabsorption because of a markedly reduced digestion of nutritional fats and proteins (64) . It may be speculated that undigested food that reaches the colon is fermented by domestic bacteria, thereby producing large amounts of dimethyl sulfone.
In line with a previous study in rats (47) , we showed that serum concentrations of TMAO (i.e., a metabolite that is derived from the gut microbiota) increased after the RYGB procedures. In light of the well-documented health benefits of the bariatric surgery (2, 3) , this finding appears rather counterintuitive because elevated circulating TMAO concentrations are currently suspected to cause severe organ damages and cardiovascular diseases (65) . With this background, our current observation that TMAO did not increase after gastric sleeve resection seems to be of particular interest. However, this finding should be interpreted with caution considering the rather low number of serum samples that were derived from subjects who underwent a sleeve gastrectomy in our study.
In conclusion, our study, for the first time to our knowledge, comprehensively captured alterations in the human metabolome associated with severe obesity as well as after distinct bariatric procedures. Respective findings will likely stimulate the detection and characterization of new metabolic pathways that play an important role in the pathophysiology of obesity-related metabolic disease.
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